GrantYard
← Back

Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)

This grant supports advanced pre-clinical research to translate nanotechnology-based cancer diagnostics and therapeutics. It funds work that matures experimental nanomedicines using nanoparticles or nano-devices with strong potential to improve treatment effectiveness, moving them toward further development in NCI translational programs.

Amount
Not stated
Type
Grant

Key facts

Key facts for Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
AmountNot stated
IssuerNational Institutes of Health
Who can applySmall businesses, companies, universities and 7 more
SectorsEdTech · HealthTech
DeadlineCloses 15 Nov 2027

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 2 days ago

  1. 85 days agoagentImported from the official source

Related

Opportunities with the same funding type or region
European Degree Exploratory ActionCloses 18 Feb 2027
Cooperative Agreement for affiliated Partner with Alaska Cooperative Ecosystem Studies Unitup to $234,460Closes 07 Dec 2026
Cooperative Agreement for affiliated Partner with Colorado Plateau Cooperative Ecosystem Studies Unitup to $150,000Closes 07 Dec 2026